![Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/ benserazide treated Parkinson's disease patients with wearing-off – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/ benserazide treated Parkinson's disease patients with wearing-off – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on](https://cyberleninka.org/viewer_images/270172/f/1.png)
Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/ benserazide treated Parkinson's disease patients with wearing-off – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on
![Molecules | Free Full-Text | Electrochemical Sensor Based on Multi-Walled Carbon Nanotubes and N-Doped TiO2 Nanoparticles for Voltametric Simultaneous Determination of Benserazide and Levodopa Molecules | Free Full-Text | Electrochemical Sensor Based on Multi-Walled Carbon Nanotubes and N-Doped TiO2 Nanoparticles for Voltametric Simultaneous Determination of Benserazide and Levodopa](https://www.mdpi.com/molecules/molecules-27-08614/article_deploy/html/images/molecules-27-08614-g001-550.jpg)
Molecules | Free Full-Text | Electrochemical Sensor Based on Multi-Walled Carbon Nanotubes and N-Doped TiO2 Nanoparticles for Voltametric Simultaneous Determination of Benserazide and Levodopa
![Maladie de Parkinson : nouvel état des lieux sur la disponibilité de SINEMET, MODOPAR et génériques (Edit du 16 avril 2019) Maladie de Parkinson : nouvel état des lieux sur la disponibilité de SINEMET, MODOPAR et génériques (Edit du 16 avril 2019)](https://vidalactus.vidal.fr/files/uploads/actus/images/SINEMET_MODOPAR_LEVODOPA_CARBIDOPA_BENSERAZIDE_maladie_Parkinson_etat_lieux_approvisionnement_MSD_TEVA_Sante.jpg)
Maladie de Parkinson : nouvel état des lieux sur la disponibilité de SINEMET, MODOPAR et génériques (Edit du 16 avril 2019)
![Acute levodopa dosing around-the-clock ameliorates REM sleep without atonia in hemiparkinsonian rats | npj Parkinson's Disease Acute levodopa dosing around-the-clock ameliorates REM sleep without atonia in hemiparkinsonian rats | npj Parkinson's Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41531-019-0096-2/MediaObjects/41531_2019_96_Fig1_HTML.png)
Acute levodopa dosing around-the-clock ameliorates REM sleep without atonia in hemiparkinsonian rats | npj Parkinson's Disease
Full article: Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson's disease
![Pharmaceutical quality of seven generic Levodopa/Benserazide products compared with original Madopar® / Prolopa® – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open Pharmaceutical quality of seven generic Levodopa/Benserazide products compared with original Madopar® / Prolopa® – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open](https://cyberleninka.org/viewer_images/971477/f/1.png)
Pharmaceutical quality of seven generic Levodopa/Benserazide products compared with original Madopar® / Prolopa® – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open
![Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson's disease patients with wearing-off: efficacy, safety and feasibility—an open-label, 6-week study | SpringerLink Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson's disease patients with wearing-off: efficacy, safety and feasibility—an open-label, 6-week study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00702-009-0344-4/MediaObjects/702_2009_344_Fig1_HTML.gif)
Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson's disease patients with wearing-off: efficacy, safety and feasibility—an open-label, 6-week study | SpringerLink
![PDF) Melevodopa/carbidopa effervescent formulation in the treatment of motor fluctuations in advanced Parkinson's disease | Juan Burguera and Juan Gómez-esteban - Academia.edu PDF) Melevodopa/carbidopa effervescent formulation in the treatment of motor fluctuations in advanced Parkinson's disease | Juan Burguera and Juan Gómez-esteban - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/42029925/mini_magick20190218-15098-1qujxso.png?1550499289)
PDF) Melevodopa/carbidopa effervescent formulation in the treatment of motor fluctuations in advanced Parkinson's disease | Juan Burguera and Juan Gómez-esteban - Academia.edu
![Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/ benserazide treated Parkinson's disease patients with wearing-off | SpringerLink Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/ benserazide treated Parkinson's disease patients with wearing-off | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00702-015-1449-6/MediaObjects/702_2015_1449_Fig2_HTML.gif)
Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/ benserazide treated Parkinson's disease patients with wearing-off | SpringerLink
![Frontiers | The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program Frontiers | The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program](https://www.frontiersin.org/files/Articles/1036068/fneur-13-1036068-HTML/image_m/fneur-13-1036068-g001.jpg)